Market Intelligence chevron_right Medical Care chevron_right Active Pharmaceutical Ingredients (API) CDMO
Global Report 2025

Global Active Pharmaceutical Ingredients (API) CDMO Market Growth (Status and Outlook) 2025-2031

calendar_todayPublished: Jun 2025 descriptionPages: 115 categoryCategory: Medical Care
cloud_downloadRequest Sample Report
mailPre-Order Enquiry
local_offerGet Discount

The global Active Pharmaceutical Ingredients (API) CDMO market size is predicted to grow from US$ 65750 million in 2025 to US$ 107310 million in 2031; it is expected to grow at a CAGR of 8.5% from 2025 to 2031.

Active Pharmaceutical Ingredient (API) Contract Development and Manufacturing Organization (CDMO) provides services related to the development, manufacturing, and supply of active pharmaceutical ingredients used in the formulation of pharmaceutical products. API CDMOs play a crucial role in the pharmaceutical industry by assisting pharmaceutical companies in bringing their drug products to market efficiently and cost-effectively.

This Insight Report provides a comprehensive analysis of the global Active Pharmaceutical Ingredients (API) CDMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity.

Key Features:

  • Market shares and growth opportunities of Active Pharmaceutical Ingredients (API) CDMO market by product type
  • Application key players and key regions

Segmentation by Type:

  • Macromolecular API
  • Small Molecule API

Segmentation by Application:

  • Clinical
  • Commercial
  • Others

Market by Region:

  • Americas
  • APAC
  • Europe
  • Middle East & Africa

Company's Coverage:

  • Recipharm
  • Cambrex Corporation
  • Patheon (Thermo Fisher Scientific)
  • CordenPharma
  • Lonza
  • Siegfried
  • Catalent
  • Boehringer Ingelheim
  • Piramal Group
  • AbbVie
  • SGS Quay Pharmaceuticals
  • Aenova Group
  • Curia
  • Sterling Pharma Solutions
  • Eurofins CDMO

Key Questions Addressed in this Report:

Frequently Asked Questions

What is the USP of the report? expand_more
Active Pharmaceutical Ingredients (API) CDMO report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
What are the key content of the report? expand_more
Active Pharmaceutical Ingredients (API) CDMO report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
What are the value propositions and opportunities offered in this market research report? expand_more
Active Pharmaceutical Ingredients (API) CDMO report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.